From Kalpataru and Symbiotec to Tata Capital, here are 5 upcoming IPOs to keep an eye on in July 2025. GST your subscriber ready!
What’s Brewing
- Kalpataru Ltd
- Price band: ₹387–₹414; IPO opens June 24, lists July 1 moneycontrol.com+1zerodha.com+1.
- Sector: Infra — steady cash flows, good order book, mid-cap watchlist staple.
- Symbiotec Pharmalab
- Plans a billion-dollar IPO within 12 months; focused on hormone API manufacturing economictimes.indiatimes.com.
- Tata Capital
- A large-cap NBFC preparing a ₹17,200 crore IPO, likely in July after SEBI green signal economictimes.indiatimes.com.
- NSE
- Might list by May next year after settling regulatory issues; valuation could be ~₹1 lakh crore reuters.com.
Why You Should Watch
- Kalpataru: Infra remains a long-term story; solid earnings outlook.
- Symbiotec: Tailwinds in pharma, especially APIs; global demand rising.
- Tata Capital: Strong parentage + huge market presence — could be blockbuster.
- NSE IPO: A rare public listing from the exchange itself — institutional favorite.
Strategy Snapshot
- Kalpataru: Retail investors could consider small exposure — good for diversification.
- Pharma & API: Symbiotec is niche high-growth; suited for those targeting global pharma supply chains.
- Large-cap NBFCs: Tata Capital fits conservative portfolios; pending details on valuation.
- Exchange IPOs: NSE is for institutional and HNI-focused portfolios due to likely high floats.
Related:
❓FAQs
Q1: When do these IPOs open?
Kalpataru opens June 24 (closes June 26), listing on July 1. Tata Capital expected mid-July.
Q2: Which IPO is safest?
Tata Capital seems safest due to parent backing and size. Kalpataru is infra with stable growth — moderate risk.
Q3: How to apply?
Track via your broker’s IPO section (like Zerodha, Groww, Angel One), apply during the subscription window.